Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV2024-05-08 | Chg.-9.8101 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,025.9800EUR | -0.48% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -6.27 | 3.80 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.34% | 18.00% | 16.26% | 20.08% | 22.72% |
| Sharpe ratio | -0.30 | 1.59 | 0.00 | -0.13 | 0.11 |
| Best month | +13.23% | +13.23% | +13.23% | +13.23% | +13.23% |
| Worst month | -6.27% | -6.27% | -6.27% | -10.88% | -10.88% |
| Maximum loss | -11.21% | -11.21% | -15.74% | -30.29% | -32.04% |
| Outperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,022.1000 | +6.19% | +11.38% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 217.6800 | +7.99% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,025.9800 | +3.82% | +3.58% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,193.9900 | +8.71% | +25.60% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,395.8201 | +7.23% | +24.32% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 356.4500 | +7.54% | +28.30% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 321.0700 | +9.00% | +28.23% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 197.6700 | +1.66% | +2.07% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,809.7600 | +6.65% | +14.21% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 146.8000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 588.7400 | +5.06% | +9.22% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,532.1299 | +6.06% | +10.97% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 193.9100 | +3.23% | +3.20% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.1400 | +4.11% | +5.73% | |
| Candriam Equities L Biotech.R US... | reinvestment | 262.3400 | +6.38% | +13.36% | |
| Candriam Equities L Biotechnolo... | reinvestment | 826.3100 | +5.45% | +10.60% | |
| Candriam Equities L Biotechnolog... | paying dividend | 754.6700 | +5.42% | +10.50% |
Performance
| YTD | -0.40% | ||
|---|---|---|---|
| 6 Months | +14.97% | ||
| 1 Year | +3.82% | ||
| 3 Years | +3.58% | ||
| 5 Years | +36.23% | ||
| 10 Years | - | ||
| Since start | +35.07% | ||
| Year | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
